Search Results

You are looking at 1 - 10 of 10 items for :

  • "polycythemia vera" x
  • Refine by Access: Content accessible to me x
Clear All
Orvosi Hetilap
Authors: Péter Dombi, Árpád Illés, Judit Demeter, Lajos Homor, Zsófia Simon, Ádám Kellner, Éva Karádi, Erika Valasinyószki, Miklós Udvardy, and Miklós Egyed

neoplasms. Eur J Haematol. 2015; 95: 270–279. 3 Tefferi A. Polycythemia vera and essential thrombocythemia: 2013 update on diagnosis, risk-stratification, and management. Am J

Open access
Orvosi Hetilap
Authors: Tünde Krähling, Katalin Balassa, Nóra Meggyesi, András Bors, Judit Csomor, Árpád Bátai, Gabriella Halm, Miklós Egyed, Sándor Fekete, Péter Reményi, Tamás Masszi, Attila Tordai, and Hajnalka Andrikovics

constitutive signalling causes polycythaemia vera. Nature, 2005, 434 (7037), 1144–1148. Kralovics, R., Passamonti, F., Buser, A. S., et al.: A gain-of-function mutation of JAK2 in myeloproliferative disorders. N. Engl. J

Open access
Orvosi Hetilap
Authors: Péter Dombi, Árpád Illés, Judit Demeter, Lajos Homor, Zsófia Simon, Miklós Udvardy, and Miklós Egyed

. Med., 2013, 369 (25), 2379–2390. 3 Moulard, O., Mehta, J., Fryzek, J., et al.: Epidemiology of myelofibrosis, essential thrombocythemia, and polycythemia vera in the European

Open access
Orvosi Hetilap
Authors: Péter Dombi, Árpád Illés, Judit Demeter, Lajos Homor, Zsófia Simon, Miklós Udvardy, Éva Karádi, Ádám Kellner, and Miklós Egyed

, A., Barbui, T.: Polycythemia vera and essential thrombocythemia: 2015 update on diagnosis, risk-stratification and management. Am. J. Hematol., 2015, 90 (2), 162–173. 8

Open access

Krónikus myeloid leukaemia miatt 2003 és 2019 között a Semmelweis Egyetem Belgyógyászati és Onkológiai Klinikáján kezelt betegek adatainak elemzése

Retrospective analysis of chronic myeloid leukemia patients treated in the Department of Internal Medicine and Oncology, Semmelweis University, between 2003 and 2019

Orvosi Hetilap
Authors: Júlia Weisinger, Ilona Tárkányi, Eid Hanna, Ágnes Kárpáti, Zsolt Nagy, Botond Timár, Judit Csomor, Richárd Kiss, Ambrus Gángó, Csaba Bödör, and Judit Demeter

–357. 14 Szerafin L, Jakó J. Chronic myeloid leukaemia following polycythaemia vera (A molecularly documented case report). [Polycythaemia verát követően kialakult krónikus myeloid leukaemia

Open access

Arteria vertebralis thrombosis egy 7 éves gyermekben

Vertebral artery thrombosis in a 7-year-old child

Orvosi Hetilap
Authors: Alexandra Viczei, István Lapis, Ádám Marián Brzózka, and György Szeifert

MH, Michaelis LC, Verstovsek S. Mechanisms of thrombogenesis in polycythemia vera. Blood Rev. 2015; 29: 215–221. 10 Tatsumi T, Shenkin HA. Occlusion of the vertebral

Open access

–2720. Marchetti, M., Castoldi, E., Spronk, H. M., et al.: Thrombin generation and activated protein C resistance in patients with essential thrombocythemia and polycythemia vera. Blood, 2008, 112 (10), 4061–4068. Panova

Open access

ONE 2020; 15: e0226879. 25 Gisslinger H, Klade C, Georgiev P, et al. Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera

Open access

myelofibrosis, essential thrombocythaemia and polycythaemia vera in the European Union. Eur J Haematol. 2014; 92: 289–297. 37 Jakó J, Szerafin L

Open access
Interventional Medicine and Applied Science
Authors: Adam Hatzidakis, Nikolaos Galanakis, Elias Kehagias, Dimitrios Samonakis, Mairi Koulentaki, Erminia Matrella, and Dimitrios Tsetis

clinical presentation, BCS can be classified as fulminant, acute, subacute, or chronic [ 2 ]. The most common underlying disorders in patients with BCS are hematologic abnormalities, such as polycythemia vera and essential thrombocytosis [ 3 ]. In Western

Open access